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Unspecialized cells that can renew themselves and give rise to multiple diﬀerentiated cell types are termed stem cells. The objective
of this study was to characterize and investigate, through molecular and biochemical analyses, the stemness of cells derived from
isolated mononucleated cells that originated from peripheral blood. The isolated mononucleated cells were separated according
to their physical characteristics (adherent and suspension), after 4 to 7 days into a 14-day culturing period in complete medium.
Our results revealed that adherent and suspension cells were positive for mesenchymal stem cell (MSC) and hematopoietic stem
cell (HSC) markers, respectively. Diﬀerentiation of adherent cells into osteoblasts was associated with expression of the OPN gene
and increasing ALP enzyme activity, while diﬀerentiation of suspension cells into osteoclasts was associated with expression of the
TRAP gene and increasing TRAP enzyme activity. In conclusion, molecular and biochemical analyses showed that mononucleated
cells consist of MSC (adherent) and HSC (suspension), and both cell types are able to diﬀerentiate into specialized cells from their
respective lineage: osteoblast (MSC) and osteoclast (HSC).
1.Introduction
Stem cell research has been one of the most fascinating and
controversial areas of contemporary biology. Progress in the
area of stem cell research raises scientiﬁc questions as rapidly
asitgeneratesnewdiscoveries.Stemcellresearchishailedfor
the potential to revolutionize the future of medicine, with its
abilitytoregeneratedamagedanddiseasedorgans.Stemcells
can be deﬁned by 3 main criteria: (1) the ability to self-renew
forseveralcelldivisions,whichisaprerequisiteforsustaining
the stem cell pool, (2) the ability to generate at the single
cell level diﬀerentiated progeny cells, generally of multiple
lineages, and (3) the ability to functionally reconstitute a
given tissue in vivo [1].
To date, several studies have shown that mesenchymal
stem cells (MSCs) and hematopoietic stem cells (HSCs) are
a d u l ts t e mc e l l sp r e s e n ti nb l o o d[ 2]. MSCs are generally
deﬁned as self-renewable, multipotent progenitor cells with
the ability to diﬀerentiate into several mesenchymal lineages,
including bone, cartilage, adipose, and muscle tissues [3].
These cells are usually identiﬁed by their plastic adherence
and surface marker expression of CD73, CD90, CD105 and
absence of CD34, CD45, HLA-DR [4]. Meanwhile, HSCs are
deﬁned by their ability to repopulate all of the hematopoietic
lineage in vivo and sustain the production of these cells for
the lifespan of the individual [5, 6]. Several laboratories
have identiﬁed HSCs as cells that demonstrate speciﬁc
p o s i t i v em a r k e r ss u c ha sKIT, Sca-1, SLAM family markers,
and lineage negativity [4, 7].
However,themethodusedforobtainingHSCsandMSCs
from peripheral blood mononucleated cells is still debated.
Isolating small amounts of MSCs detectable in peripheral2 The Scientiﬁc World Journal
blood is diﬃcult and depends on the method used. MSCs
that have been isolated are adherent and display a ﬁbrob-
lastic appearance [8]. Therefore, in this study, we further
separated the mixed population of isolated mononucleated
cells according to their physical characteristics, which are
nonadherent (suspension) and adherent, after several days of
culture selection.
Stemnessmustbeaddressedbeforeacellistobeclassiﬁed
asastemcell.Inthisstudy,thestemnessofisolatedmononu-
cleated cells that we have further separated according to
their physical characteristics was determined through the
expressionofstemnessmarkers,geneexpressionproﬁles,and
biochemical analysis of adherent and suspension mononu-
cleated cells during osteoblast and osteoclast diﬀerentiation,
respectively. Our results demonstrate that adherent and
suspension mononucleated cells show expression of MSC
m a r k e r sa n dH S Cm a r k e r s ,r e s p e c t i v e l y .T h eg e n ee x p r e s s i o n
proﬁles and biochemical analyses of adherent (MSC) and
suspension (HSC) mononucleated cells during in vitro
osteoblast and osteoclast diﬀerentiation indicate that these
cells are also capable of fully diﬀerentiating into osteoblast
andosteoclastcells.Thesestudiesdemonstratethepossibility
ofobtainingHSCandMSCpopulationfrommononucleated
blood. Our approach may lead to the improved ability to
isolate HSCs and MSCs from mononucleated peripheral
blood cells and it could lead to further research in cellular
therapy.
2.MaterialsandMethods
2.1. Isolation of Mononucleated Cells. Three samples of
peripheral blood were obtained by venipuncture from each
of 3 healthy volunteers (18–25 years old) after obtaining
their informed consent and approval from the Ethical
Committee of the Faculty of Science and Technology,
Universiti Kebangsaan Malaysia (UKM). In each blood
sample the cell culture experiment, gene expression, and
biochemical analyses were performed. Human mononucle-
ated peripheral blood cells were isolated using the Ficoll-
Paque density-gradient separation method. Firstly, the blood
samples were diluted three times with Hanks’ Balanced
Salt Solution (Sigma, USA). The diluted blood samples
were carefully layered 1:1.5 on Ficoll-Paque PLUS (GE
Healthcare, Sweden) and centrifuged at 400g for 20min
at room temperature. The mononucleated cell layer at the
plasma-Ficoll interface was washed 3 times with phosphate
buﬀer saline (PBS) and cultured in 6-well plates with
complete medium containing α-Minimal Essential Medium
(α-MEM) (Invitrogen, USA) supplemented with 10% (v/v)
newborn calf serum (NBCS) (Invitrogen, USA) and 2%
(v/v) penicillin-streptomycin solution (Invitrogen, USA) at
37◦C in a humidiﬁed atmosphere containing 5% CO2.
Approximately 8 ×105 mononuclear cells were isolated from
1mL of peripheral blood samples. The isolated cells were
cultured in complete medium for 14 days with complete
medium exchange every 3 days. Cells were transferred into
a new 6-well plate 4 to 7 days prior to separating them into
plates of either adherent or suspension cells.
2.2. Cell Culture Morphology. The morphologies of adherent
and suspension mononucleated cells were observed in vitro
at days 0, 7, and 14 using an inverted microscope (Olympus,
Model: CKX75). Images were obtained using a digital
camera.
2.3. Diﬀerentiation of Adherent Mononucleated Cells into
Osteoblasts. Approximately 1 × 105 cell/mL mononucleated
c e l l sc u l t u r e di ns u s p e n s i o ni nc o m p l e t em e d i u mw e r e
supplementedwithdiﬀerentiationfactors,50μg/mLascorbic
acid (Sigma, USA) and 10mM β-glycerophosphate (Sigma,
USA), for 14 days to induce diﬀerentiation into osteoblasts.
Cultures were maintained at 37◦Cw i t h5 %C O 2.C e l l s
cultured in complete medium without diﬀerentiation factors
were used as controls.
2.4. Diﬀerentiation of Suspension Mononucleated Cells into
Osteoclasts. For osteoclast diﬀerentiation, 1 × 105 cell/mL
of suspension mononucleated cells were cultured in com-
plete medium supplemented with growth factors, 50ng/mL
recombinant sRANKL and 25ng/mL macrophage-colony
stimulating factor (M-CSF) and cultured for 10 days. Cul-
tures were maintained at 37◦Cw i t h5 %C O 2. Cells cultured
in complete medium without growth factors were used as
controls.
2.5. Reverse-Transcriptase Polymerase Chain Reaction (RT-
PCR) Ampliﬁcation. Total RNA was extracted using TRI
Reagent (Sigma, USA) following the manufacturer’s instruc-
tions. Total RNA was extracted from human adherent and
suspension mononucleated cells that had been cultured for
14 days in complete medium, 10 and 14 days in osteoclast
and osteoblast diﬀerentiation medium, respectively. One
microgram total RNA was subjected to RT-PCR ampliﬁ-
cation using an Access RT-PCR System kit provided by
Promega, USA. First-strand complementary DNA (cDNA)
was synthesized by reverse transcription at 45◦C for 45min,
followed by Avian Myeloblastosis Virus reverse transcrip-
tase inactivation at 94◦C for 2min. Second-strand cDNA
synthesis and PCR ampliﬁcation consisted of 40 cycles of
denaturation at 94◦C for 30sec, primer annealing for 1min
and extension at 68◦C for 2min, with a ﬁnal cycle at 68◦C
for 7min. The speciﬁc primer sequences used are shown
in Table 1. Each RT-PCR product was then sequenced and
analyzed.
2.6. Alkaline Phosphatase Assay. Biochemical analysis for
osteoblast diﬀerentiation was conducted by Alkaline Phos-
phatase (ALP) enzyme assays of adherent cells cultured in
osteoblast diﬀerentiation and complete medium on days 0,
3, 5, 7, 10, and 14. Adherent cells cultured in complete
medium were used as the control. The cells were washed
with PBS and then incubated in 0.1M NaHCO3-Na2CO3
(pH 10.0), 0.1% (v/v) Triton X-100, 2mM MgSO4 and
6mM p-nitrophenyl phosphate (ρNPP) (Sigma, USA) for
30min at 37◦C. The reaction was stopped by adding 1mL
1.5M NaOH, and absorbance was measured at 405nm.
ALP activity is represented as the speciﬁc activity. The
speciﬁc activity was determined by the unit activity (U)The Scientiﬁc World Journal 3
Table 1: Human primer sequences used in RT-PCR.
Gene Primer Sequence Annealing temperature (◦C) Expected size (bp)
GAPDH Sense 5 CCATGGAGAAGGCTGG3 
55 195
Antisense 5 CAAAGTTGTCAGGATGACC3 
SLAMF1 Sense 5 CTCTGCGTTCTGCTCCTA3 C 54 403
Antisense 5 TTGGTCACTTCTGGGTCTG3 
KIT Sense 5 TCCTTGACCTTCGTGCTGT3 
53 316
Antisense 5 CCTTCCTGCTTTCCCGTAT3 
CD105 Sense 5 GCTCCCTCTGGCTGTTG3 
61 290
Antisense 5 TTACACTGAGGACCAGAAGC3 
TRAP Sense 5 GACCACCTTGGCAATGTCTCTG3 
58 176
Antisense 5 TGGCTGAGGAAGTCATCTGAGTTG3 
OPN Sense 5 GACCTGCCAGCAACCGAAGT3 
56 452
Antisense 5 GGGTCTACAACCAGCATA3 
per total protein content (mg), and the protein content was
measured using the Bradford method. One unit of activity
is represented by the hydrolysis of 1μM ρNPP per minute at
37◦C.TheALP-speciﬁcactivitywaspresentedinapercentage
value, which was compared to the ALP-speciﬁc activity in
the control cells (cells cultured in complete medium). ALP-
speciﬁc activity in the control cells was used to determine the
basal activity rate (100%).
2.7. Tartrate-Resistant Acid Phosphatase Assay. Biochemical
analysis for osteoclast diﬀerentiation was conducted by
Tartrate-Resistant Acid Phosphatase (TRAP) enzyme assays
of suspension cells cultured in osteoclast diﬀerentiation and
complete medium on days 0, 3, 5, 7 and 10. Suspension
cells cultured in complete medium were used as the control.
The cells were washed with PBS. The TRAP enzyme was
assayed in cell extracts and complete medium using ρNPP
as a substrate in an incubation medium (1mL) containing
the following components: 10mM ρNPP, 0.1M Na-acetate
(pH 5.8), 0.15M KCl, 0.1% (v/v) Triton X-100, 10mMNa-
tartrate, 1mMascorbic acid, and 0.1mMFeCl3. The mixture
was incubated for 1 hour and the reaction was stopped by
adding 500μL of 0.3MNaOH and immediately read at a
wavelength of 405nm. TRAP activity is expressed as the
hydrolysis of 1μMp N P Pp e rm i na t3 7 ◦C. The speciﬁc
activity was determined by unit activity (U) per total protein
content (mg), as mentioned previously. The TRAP-speciﬁc
activity was presented in a percentage value, which was
compared to TRAP-speciﬁc activity in the control cells
(suspension cells cultured in complete medium). TRAP-
speciﬁc activity in the control cells was used to determine the
basal activity rate (100%).
2.8.StatisticalAnalysis. Datawerestatisticallyanalyzedusing
paired t-tests. Data were considered statistically signiﬁcant at
P<0.05.
3. Results
3.1. Morphology and Characteristics of Isolated Cells. The
freshly isolated mononucleated cells from human peripheral
blood (Figure 1(a)) were morphologically heterogeneous.
Further culturing of these cells in complete medium for
7-day produced two diﬀerent types of cells. One cell type
was round and ﬂoated in the medium or loosely attached
to the culture dish (suspension cells); another cell type
ﬁrmly attached with a diﬀerent morphological appearance
(adherent cells) (Figures 1(b) and 2(b)). The adherent
and suspension mononucleated cells were then separated;
mononucleatedcellsthatalreadyattachedwerelefttoexpand
in the same dishes, while suspension mononucleated cells
were transferred into new 6-well plates.
Adherent and suspension mononucleated cells were sep-
arated after 7 days in vitro culture selection. Both adherent
and suspension mononucleated cells were maintained in
complete medium for 14 days of culture, to deplete most
of the unwanted cells and allow time for proliferation prior
to enriching the cells for analysis. After 14 days in culture,
the adherent and suspension cells became more morpholog-
ically homogeneous; most of the cells in suspension were
morphologically round (Figure 1(c)), while the adherent
mononucleated cells showed a spindle-shaped ﬁbroblast-like
morphology (Figure 1(d)). However, morphological charac-
teristics alone are insuﬃcient to demonstrate the presence
of mononucleated stem cells. Thus, the mononucleated cells
were further characterized by a molecular approach (RT-
PCR analysis), using human-speciﬁc stem cell markers.
3.2. Expression of Mesenchymal Stem Cell (MSC) and Hema-
topoietic Stem Cell (HSC) Markers. Adherent and suspen-
sion mononucleated cells from human peripheral blood
(Figure 3(a))w e r ea n a l y z e db yR T - P C Rf o rt h ep r e s e n c eo f
MSC and HSC markers. In this study, we used CD105 as
an MSC marker, SLAM F1 as an HSC marker, and KIT as
stem cell marker. Adherent and suspension mononucleated
cells (Figure 2) were shown to express MSC and HSC
markers,respectively.Furthermore,adherentandsuspension
mononucleated cells were negative for the presence of HSC
and MSC markers, respectively. RT-PCR showed ampliﬁca-
tion of products of the expected size for the MSC marker:
CD105 (290bp), HSC marker: SLAM F1 (403bp), and stem
cell marker: KIT (316bp).
3.3. Gene Expression Proﬁles during Osteoblast and Osteo-
clast Diﬀerentiation. Gene expression proﬁles of adherent4 The Scientiﬁc World Journal
and suspension mononucleated cells during osteoblast and
osteoclast diﬀerentiation were carried out to evaluate the
capacities of MSCs from adherent and HSCs from suspen-
sion mononucleated cells to diﬀerentiate into specialized
cells from their expected lineage. RT-PCR was performed
to examine how gene expression of MSC, HSC, osteoblast
and osteoclast marker proﬁles changes during osteoblast and
osteoclast diﬀerentiation. RT-PCR analyses were conducted
simultaneously at days 0, 5, 10, and 14 for osteoblast
diﬀerentiation and at days 0, 3, 7, and 10 for osteoclast
diﬀerentiation. RT-PCR analyses showed diﬀerent levels of
gene expression in (Figure 3) mononucleated cells during
osteoblast and osteoclast diﬀerentiation. The markers for
MSCs (CD105), HSCs (SLAM F1), osteoblasts (OPN), and
osteoclasts (TRAP) were used. As seen in Figure 3(a), the
expression of the osteoblast marker was low during early
osteoblast diﬀerentiation but increased over time, similar
to osteoclast diﬀerentiation of mononucleated cells and
increased osteoclast marker expression throughout the dif-
ferentiationperiod.Theincreasesinosteoblastandosteoclast
marker transcription suggest that the mononucleated cells
diﬀerentiated into mature osteoblast and osteoclast cells,
respectively. Moreover, the expression of stemness markers
in both adherent and suspension suspension mononucleated
cells decreased over the time in diﬀerentiation media, which
indicates that the unspecialized mononucleated stem cells
have successfully diﬀerentiated.
3.4. Biochemical Analysis during Osteoblast and Osteoclast
Diﬀerentiation. Biochemical analyses during osteoblast and
osteoclast diﬀerentiation were carried out by two diﬀerent
enzyme assays: ALP and TRAP assays. ALP is a relative
marker of osteoblast diﬀerentiation, while TRAP is a bio-
chemical marker for osteoclasts. Figure 4 shows the percent-
age of ALP-speciﬁc activity during 14 days of osteoblast
diﬀerentiation. The percentage of ALP-speciﬁc activities
in adherent mononucleated cells cultured in osteoblast
diﬀerentiation medium gradually increased from day 3 to
day 14 of osteoblast diﬀerentiation. This was statistically
signiﬁcant (P<0.05) starting from days 7, 10, and 14
of osteoblast diﬀerentiation (Figure 4). Therefore, adherent
cells, which consist of MSCs, were successfully diﬀerentiated
into osteoblasts.
Meanwhile, biochemical analysis using TRAP enzyme
assays during osteoclast diﬀerentiation showed that the per-
centage of TRAP-speciﬁc activities increased in suspension
mononucleated cells cultured in osteoclast diﬀerentiation
medium starting from day 3 to day 10 of the induction of
diﬀerentiation (Figure 5). Statistical analysis using a paired
t-test for TRAP enzyme assays showed a signiﬁcant increase
(P<0.05) at days 5, 7, and 10 of diﬀerentiation. These
resultsindicatethatthesuspensioncellsweresuccessfullydif-
ferentiated into osteoclasts, as TRAP is used as a biochemical
marker for osteoclasts.
4. Discussion
The isolation of mononucleated cells was based on den-
sity gradient centrifugation using Ficoll-Paque, in which
diﬀerences in density separate mononucleated cells from
other blood cells. As shown in Figure 1(a), the isolated
mononucleated cells are in a heterogeneous population.
After 7 days of culture in complete medium, we obtained
a mixed population with a low number of ﬁbroblast-like
cells (adherent) and suspension cells that have one round
nucleus (e.g., lymphocytes, monocytes, and macrophages)
(Figure 1(b)). Both adherent and suspension cells were
cultured separately for additional 7 days. After a total of 14
daysofinvitrocultureselection,theadherentandsuspension
cells became more morphologically homogenous (Figures
1(c) and 1(d))a sw es u s p e c tt h a tam a j o r i t yo fd i ﬀerentiated
and precursor cells died due to their short lifespan, for
example, granulocytes (30–40 minutes in the peripheral
blood with a total lifespan of 7–13 days that varied under
certain pathological conditions), monocytes (5–7 days), and
platelets (3–5 days) [9].
For a particular cell type to be classiﬁed as a stem
cell, proof of stemness through proper and accepted char-
acterization tests must be addressed. Stemness refers to
the stem cell properties of having a certain gene or genes
whose expression makes possible both the potential for self-
renewal and multilineage diﬀerentiation [10]. In our study,
CD105 w a su s e da sa nM S Cm a r k e r ,SLAM F1 as an HSC
marker, and KIT as stem cell marker (Figure 3(a)). KIT or
c - K i to rC D 1 1 7i saS t e mC e l lF a c t o r( S C F )r e c e p t o ra n d
expression of KIT in both types of stem cells is important
as it acts on migration, adhesion, survival, proliferation, and
diﬀerentiation [11]. KIT expression was reported in adult
bone marrow hematopoietic and mesenchymal stem cells
[12, 13] as well as fetal and umbilical cord hematopoietic
stem cells [14, 15]. According to Hassan [16], its expression
correlates with the self-renewal function of these fetal and
adult stem cells. Moreover, KIT was found expressed in both
human and mouse undiﬀerentiated embryonic stem cells
with a role in maintaining their undiﬀerentiated state and
correlation with functional measures of their pluripotency
[17–21]. CD105 or endoglin is a type I membrane glyco-
protein, which is located on the cell surface and is also part
of the TGF-β receptor complex [22]. CD105 is involved in
regulating the proliferation of MSCs [23]. SLAMF1 is a cell
surface receptor important in the self-renewal of HSCs [24]
and is the founding member of the SLAM family of cell
surface receptors [25, 26]. SLAM family members regulate
the proliferation and activation of lymphocytes [27, 28].
This study revealed that adherent cells were positive
for the expression of MSC markers, with an absence of
HSC marker expression. By contrast, suspension cells were
positive for the presence of HSC markers, while MSC marker
expression was absent (Figure 2). These data indicate that
adherent mononucleated cells with ﬁbroblast-like morphol-
ogy are MSCs, while HSCs are suspension mononucleated
cells with round nuclear morphology.
The ability to generate diﬀerentiated progeny is one
stem cell property (stemness). The stemness of adherent
and suspension mononucleated cells was further determined
by gene expression proﬁles and biochemical analysis during
osteoblast and osteoclast diﬀerentiation. MSCs have the
ability to diﬀerentiate into all of the mesenchymal lineages,The Scientiﬁc World Journal 5
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Figure 1: Human mononucleated cell morphology. (a) Mononucleated cells after isolation, (b) mononucleated cells after 7 days culture,
(c) suspension cells, and (d) adherent mononucleated cells after 14-day culture. Each photomicrograph above is representative of three
independent experiments (× 200). Cells in suspension: the solid arrow. Adherent cells: the dashed arrow.
while HSCs have the ability to repopulate the hematopoietic
lineages.Thus,adherentcells(MSCs)werediﬀerentiatedinto
osteoblast cells that originated from mesenchymal lineages,
while suspension cells (HSCs) were induced to diﬀerentiate
into osteoclast cells that originated from hematopoietic
lineages.
Gene expression proﬁles demonstrated that the stemness
markers were downregulated upon the induction of diﬀeren-
tiation, resulting in decreased marker expression. All of the
stemness markers, such as CD105 and SLAM F1, which have
been used to examine gene expression proﬁles, play a signif-
icant role in the maintenance of the undiﬀerentiated state of
cells by stimulating proliferation [23, 24, 29]. Therefore, the
downregulated of these genes might play important roles in
theinitiationofthediﬀerentiationprocessinmononucleated
cells. By contrast, osteoblast and osteoclast markers were
upregulated during diﬀerentiation, which resulted in the
increased expression of these markers.
ALP [30],osteopontin(OPN),andosteocalcin(OC)[31]
genes have been widely used as osteoblast markers, while
cathepsin K (CATK)a n dTRAP are used as osteoclast
markers [32]. The increase in OPN gene transcription
(Figure 3(a)) shows that mononucleated cells diﬀerentiate
intomatureosteoblastcells[9],whileincreasedexpressionof
TRAP (Figure 3(b)) indicates that mononucleated cells have
diﬀerentiatedintoosteoclastcells[33,34].Thehousekeeping
gene (GAPDH) is constitutively expressed at the same level
throughout diﬀerentiation. This ﬁnding is in agreement with
previous ﬁndings by Barber et al. [35], which showed that
GAPDH is constitutively expressed at a relatively constant
level in mammalian cells or tissues (Figure 3).
Biochemical analysis was performed to further conﬁrm
that adherent and suspension mononucleated cells were able
to diﬀerentiate into osteoblast and osteoclast cells, respec-
tively, when exposed to the appropriate induction medium.
In addition to the increased expression of OPN, osteoblasts6 The Scientiﬁc World Journal
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Figure 2: Expression of hematopoietic stem cell (HSC) and mesenchymal stem cell (MSC) markers in mononucleated cells derived from
peripheral blood. RT-PCR analysis was performed using total RNA isolated from adherent and suspension mononucleated cells of human
peripheral blood. CD105 w a su s e da sa nM S Cm a r k e r ,SLAM F1 as an HSC marker, and KIT as a stem cell factor (SCF) marker. GAPDH
was used as a positive control for RT-PCR analysis. A 100bp DNA ladder was used to identify the approximate size of the RT-PCR products.
The RT-PCR products were observed by electrophoresis on 1% (w/v) agarose gels and stained with ethidium bromide. All RT-PCR products
were conﬁrmed with DNA sequencing after cloning and were found to be 100% identical to the known sequences obtained from BLAST
analysis.
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Figure 3: Gene expression proﬁles during osteoblast and osteoclast diﬀerentiation from human mononucleated cells. Adherent and
suspension mononucleated cells were induced to diﬀerentiate into osteoblast (a) and osteoclast (b) cells, respectively. The expression proﬁles
of OPN (234bp) and TRAP (176bp) were used as osteoblast and osteoclast markers, respectively. The expression proﬁle of GAPDH was
used as a control.
also actively produce the ALP enzyme [32]. Therefore, ALP
enzymeactivityassayswerecarriedouttodetectthepresence
ofactiveosteoblastcells,whenadherentcellswereculturedin
the diﬀerentiation osteoblast medium that contains ascorbic
acid and β-glycerophosphate. As seen in Figure 4,A L P
enzyme activity was signiﬁcantly higher from day 7 until
day 14 of osteoblast diﬀerentiation in the presence of these
two diﬀerentiation factors. This ﬁnding is in agreement with
previous ﬁndings in which Zainal Ariﬃn et al. [9], Zainol
Abidin et al. [33, 34], and Yazid et al. [36] showed that
ALP activity increased during osteoblast diﬀerentiation. The
ALP enzyme is associated with bone formation of osteoblast
cells [37] as it is involved in producing high levels of local
phosphate ions that provide the chemical conditions needed
for mineral deposition, which induces the mineralization of
osteoblast cells [38].
TRAP enzyme activity assays were carried out to detect
the presence of osteoclast cells when suspension cells were
cultured in the diﬀerentiation osteoclast medium, which
contains RANKL and M-CSF. TRAP enzymes were secreted
at the highest levels at day 10 of osteoclast diﬀerentiation
(Figure 5). These data are also in accord with the ﬁndings
of Zainal Ariﬃn et al. [9], Zainol Abidin et al. [33, 34], and
Yazid et al. [36], who reported that TRAP enzyme activity
washighestatday10ofosteoclastdiﬀerentiationfrommouse
cells in suspension. Furthermore, the increased activity of
TRAP enzymes was concurrent with increased expression
of the TRAP gene in the gene expression proﬁle analyses.The Scientiﬁc World Journal 7
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Figure 4: Percentage of ALP-speciﬁc activity of adherent mononu-
cleated cells during osteoblast diﬀerentiation. There was signiﬁ-
cantlyincreasedALPactivityinadherentcellsculturedinosteoblast
diﬀerentiationmediumatdays7,10,and14ofdiﬀerentiation,using
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enzyme activity compared to control cells. Results are presented as
the mean ± SD (n = 3). ALP-speciﬁc activity in control cells was
used for the basal rate (100%).
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Figure 5: Percentage of TRAP-speciﬁc activity of suspension
mononucleated cells during osteoclast diﬀerentiation. There was
a signiﬁcant increase in TRAP activity in adherent cells cultured
in osteoblast diﬀerentiation medium at day 5, 7, and 10 of
diﬀerentiation, using a paired t-test ∗indicates a signiﬁcant (P<
0.05) increase in TRAP enzyme activity compared to control cells.
Results are presented as the mean ± SD (n = 3). TRAP-speciﬁc
activity in control cells was used for the basal rate (100%).
The adherent and suspension mononucleated cells, there-
fore, had the capacity to diﬀerentiate into osteoclasts and
osteoblasts, respectively, when exposed to the appropriate
induction medium. Thus, in this study, the gene expression
proﬁle and biochemical analyses of mononucleated cells
during diﬀerentiation revealed that both adherent and sus-
pension mononucleated cells were successfully diﬀerentiated
into more specialized cells.
5. Conclusions
Using the expression of stem cell markers, adherent and sus-
pension mononucleated cells were shown to have MSC and
HSC characteristics, respectively. Observation of the gene
expression proﬁles and biochemical analyses of adherent and
suspensionmononucleatedcellsduringosteoblastandosteo-
clast diﬀerentiation, respectively, indicates that these cells are
also capable of fully diﬀerentiating into their respective cell
types. Therefore, our isolation procedure could be useful as
the ﬁrst step in isolating more homogeneous populations
of MSCs and HSCs, which are essential for functional and
molecular investigations into mechanisms that regulate their
self-renewal, lineage restriction, and diﬀerentiation.
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